4//SEC Filing
Taylor Daphne 4
Accession 0001209191-23-016783
CIK 0001671584other
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:41 PM ET
Size
11.7 KB
Accession
0001209191-23-016783
Insider Transaction Report
Form 4
Taylor Daphne L
SVP, CFO
Transactions
- Award
Restricted Stock Unit
2023-03-03+11,000→ 11,000 total→ Common Stock (11,000 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-03-04−1,583→ 3,167 total→ Common Stock (1,583 underlying) - Exercise/Conversion
Common Stock
2023-03-04+1,583→ 5,423 total - Award
Stock Option (right to buy)
2023-03-03+11,000→ 11,000 totalExercise: $2.15Exp: 2033-03-02→ Common Stock (11,000 underlying)
Footnotes (4)
- [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F2]The option vests in three approximately equal annual installments beginning on March 2, 2024.
- [F3]The RSUs vest in three approximately equal annual installments beginning on March 2, 2024.
- [F4]On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023.
Documents
Issuer
Aptevo Therapeutics Inc.
CIK 0001671584
Entity typeother
Related Parties
1- filerCIK 0001393549
Filing Metadata
- Form type
- 4
- Filed
- Mar 6, 7:00 PM ET
- Accepted
- Mar 7, 4:41 PM ET
- Size
- 11.7 KB